Evidence map›Paper›PMID 25344409›Full record

ArticleBMC systems biology2014

Understanding disease mechanisms with models of signaling pathway activities.

Patricia Sebastian-Leon, Enrique Vidal, Pablo Minguez, Ana Conesa, Sonia Tarazona, Alicia Amadoz, Carmen Armero, Francisco Salavert, Antonio Vidal-Puig, David Montaner and 1 more

Open access · diamondAbstract read
In one paragraph

Article in BMC systems biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 56 citations in OpenAlex.

  1. Pathway Analysis Interpretation in the Multi-Omic Era.Biotech (Basel (Switzerland)) · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Patricia Sebastian-LeonDepartment of Computational Genomics, Centro de Investigación Príncipe Felipe (CIPF), Avda. Autopista del Saler, 16, 46012, Valencia, Spain. psebastian@cipf.es.
Enrique VidalDepartment of Computational Genomics, Centro de Investigación Príncipe Felipe (CIPF), Avda. Autopista del Saler, 16, 46012, Valencia, Spain. evidalo@idibell.cat.
Pablo MinguezDepartment of Computational Genomics, Centro de Investigación Príncipe Felipe (CIPF), Avda. Autopista del Saler, 16, 46012, Valencia, Spain. pablo.minguez@embl.de.
Ana ConesaDepartment of Computational Genomics, Centro de Investigación Príncipe Felipe (CIPF), Avda. Autopista del Saler, 16, 46012, Valencia, Spain. aconesa@cipf.es.
Sonia TarazonaDepartment of Computational Genomics, Centro de Investigación Príncipe Felipe (CIPF), Avda. Autopista del Saler, 16, 46012, Valencia, Spain. starazona@cipf.es.
Alicia AmadozDepartment of Computational Genomics, Centro de Investigación Príncipe Felipe (CIPF), Avda. Autopista del Saler, 16, 46012, Valencia, Spain. aamadoz@cipf.es.
Carmen ArmeroDepartment of Statistics and Operations Research, University of Valencia, Valencia, 46100, Spain. Carmen.Armero@uv.es.
Francisco SalavertDepartment of Computational Genomics, Centro de Investigación Príncipe Felipe (CIPF), Avda. Autopista del Saler, 16, 46012, Valencia, Spain. fsalavert@cipf.es.
Antonio Vidal-PuigInstitute of Metabolic Science - Metabolic Research Laboratories and Department of Clinical Biochemistry, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. ajv22@medschl.cam.ac.uk.
David MontanerDepartment of Computational Genomics, Centro de Investigación Príncipe Felipe (CIPF), Avda. Autopista del Saler, 16, 46012, Valencia, Spain. dmontaner@cipf.es.
Joaquín DopazoDepartment of Computational Genomics, Centro de Investigación Príncipe Felipe (CIPF), Avda. Autopista del Saler, 16, 46012, Valencia, Spain. jdopazo@cipf.es.
Centro de Investigacion Principe Felipe · ESCentre for Biomedical Network Research on Rare Diseases · ESUniversitat de València · ESUniversity of Cambridge · GB

Funding

British Heart Foundation RG/12/13/29853Medical Research Council G0600717Medical Research Council G0802051Medical Research Council MC_UU_12012/2Medical Research Council MC_UU_12012/5
6 · The paper itself

Abstract

backgroundUnderstanding the aspects of the cell functionality that account for disease or drug action mechanisms is one of the main challenges in the analysis of genomic data and is on the basis of the future implementation of precision medicine.

resultsHere we propose a simple probabilistic model in which signaling pathways are separated into elementary sub-pathways or signal transmission circuits (which ultimately trigger cell functions) and then transforms gene expression measurements into probabilities of activation of such signal transmission circuits. Using this model, differential activation of such circuits between biological conditions can be estimated. Thus, circuit activation statuses can be interpreted as biomarkers that discriminate among the compared conditions. This type of mechanism-based biomarkers accounts for cell functional activities and can easily be associated to disease or drug action mechanisms. The accuracy of the proposed model is demonstrated with simulations and real datasets.

conclusionsThe proposed model provides detailed information that enables the interpretation disease mechanisms as a consequence of the complex combinations of altered gene expression values. Moreover, it offers a framework for suggesting possible ways of therapeutic intervention in a pathologically perturbed system.

Indexed as

DiseaseModels, BiologicalAnimalsBiomarkersComputer SimulationGene Expression RegulationHumansInternetMiceSignal TransductionSoftwareSpecies SpecificityBiomarkers

Identifiers

PMID25344409
PMCPMC4213475
OpenAlexW2100768460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.